BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 30266815)

  • 1. Genome-Informed Targeted Therapy for Osteosarcoma.
    Sayles LC; Breese MR; Koehne AL; Leung SG; Lee AG; Liu HY; Spillinger A; Shah AT; Tanasa B; Straessler K; Hazard FK; Spunt SL; Marina N; Kim GE; Cho SJ; Avedian RS; Mohler DG; Kim MO; DuBois SG; Hawkins DS; Sweet-Cordero EA
    Cancer Discov; 2019 Jan; 9(1):46-63. PubMed ID: 30266815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structurally Complex Osteosarcoma Genomes Exhibit Limited Heterogeneity within Individual Tumors and across Evolutionary Time.
    Rajan S; Zaccaria S; Cannon MV; Cam M; Gross AC; Raphael BJ; Roberts RD
    Cancer Res Commun; 2023 Apr; 3(4):564-575. PubMed ID: 37066022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Complexity of Osteosarcoma and Its Implication for Preclinical and Clinical Targeted Therapies.
    Schott C; Shah AT; Sweet-Cordero EA
    Adv Exp Med Biol; 2020; 1258():1-19. PubMed ID: 32767231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma.
    Kinnaman MD; Zaccaria S; Makohon-Moore A; Arnold B; Levine MF; Gundem G; Arango Ossa JE; Glodzik D; Rodríguez-Sánchez MI; Bouvier N; Li S; Stockfisch E; Dunigan M; Cobbs C; Bhanot UK; You D; Mullen K; Melchor JP; Ortiz MV; O'Donohue TJ; Slotkin EK; Wexler LH; Dela Cruz FS; Hameed MR; Glade Bender JL; Tap WD; Meyers PA; Papaemmanuil E; Kung AL; Iacobuzio-Donahue CA
    Cancer Res; 2023 Nov; 83(22):3796-3812. PubMed ID: 37812025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomics and the Immune Landscape of Osteosarcoma.
    Wu CC; Livingston JA
    Adv Exp Med Biol; 2020; 1258():21-36. PubMed ID: 32767232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma.
    Smida J; Xu H; Zhang Y; Baumhoer D; Ribi S; Kovac M; von Luettichau I; Bielack S; O'Leary VB; Leib-Mösch C; Frishman D; Nathrath M
    Int J Cancer; 2017 Aug; 141(4):816-828. PubMed ID: 28494505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary Application of Precision Genomic Medicine Detecting Gene Variation in Patients with Multifocal Osteosarcoma.
    Zhang HQ; Li MH; Gao P; Lan PH; Fan B; Xiao X; Lu YJ; Chen GJ; Wang Z
    Orthop Surg; 2016 May; 8(2):129-38. PubMed ID: 27384721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma.
    Negri GL; Grande BM; Delaidelli A; El-Naggar A; Cochrane D; Lau CC; Triche TJ; Moore RA; Jones SJ; Montpetit A; Marra MA; Malkin D; Morin RD; Sorensen PH
    J Pathol; 2019 Nov; 249(3):319-331. PubMed ID: 31236944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.
    Chen X; Bahrami A; Pappo A; Easton J; Dalton J; Hedlund E; Ellison D; Shurtleff S; Wu G; Wei L; Parker M; Rusch M; Nagahawatte P; Wu J; Mao S; Boggs K; Mulder H; Yergeau D; Lu C; Ding L; Edmonson M; Qu C; Wang J; Li Y; Navid F; Daw NC; Mardis ER; Wilson RK; Downing JR; Zhang J; Dyer MA;
    Cell Rep; 2014 Apr; 7(1):104-12. PubMed ID: 24703847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-cost and clinically applicable copy number profiling using repeat DNA.
    Abujudeh S; Zeki SS; van Lanschot MCJ; Pusung M; Weaver JMJ; Li X; Noorani A; Metz AJ; Bornschein J; Bower L; Miremadi A; Fitzgerald RC; Morrissey ER; Lynch AG
    BMC Genomics; 2022 Aug; 23(1):599. PubMed ID: 35978291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data.
    Alkodsi A; Louhimo R; Hautaniemi S
    Brief Bioinform; 2015 Mar; 16(2):242-54. PubMed ID: 24599115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drug.
    Murakami T; Igarashi K; Kawaguchi K; Kiyuna T; Zhang Y; Zhao M; Hiroshima Y; Nelson SD; Dry SM; Li Y; Yanagawa J; Russell T; Federman N; Singh A; Elliott I; Matsuyama R; Chishima T; Tanaka K; Endo I; Eilber FC; Hoffman RM
    Oncotarget; 2017 Jan; 8(5):8035-8042. PubMed ID: 28030831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The degree of mitochondrial DNA methylation in tumor models of glioblastoma and osteosarcoma.
    Sun X; Vaghjiani V; Jayasekara WSN; Cain JE; St John JC
    Clin Epigenetics; 2018 Dec; 10(1):157. PubMed ID: 30558637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic heterogeneity of osteosarcoma - shift from single candidates to functional modules.
    Poos K; Smida J; Maugg D; Eckstein G; Baumhoer D; Nathrath M; Korsching E
    PLoS One; 2015; 10(4):e0123082. PubMed ID: 25848766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma.
    Maire G; Martin JW; Yoshimoto M; Chilton-MacNeill S; Zielenska M; Squire JA
    Cancer Genet; 2011 Mar; 204(3):138-46. PubMed ID: 21504713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of osteosarcoma genomics and its impact on targeted therapy: an international collaboration to conquer human osteosarcoma.
    Yang JL
    Chin J Cancer; 2014 Dec; 33(12):575-80. PubMed ID: 25418192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine.
    Subbiah V; Wagner MJ; McGuire MF; Sarwari NM; Devarajan E; Lewis VO; Westin S; Kato S; Brown RE; Anderson P
    Oncotarget; 2015 Dec; 6(38):40642-54. PubMed ID: 26510912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future directions in the treatment of osteosarcoma.
    Bishop MW; Janeway KA; Gorlick R
    Curr Opin Pediatr; 2016 Feb; 28(1):26-33. PubMed ID: 26626558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations.
    Bousquet M; Noirot C; Accadbled F; Sales de Gauzy J; Castex MP; Brousset P; Gomez-Brouchet A
    Ann Oncol; 2016 Apr; 27(4):738-44. PubMed ID: 26787232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.
    Man TK; Lu XY; Jaeweon K; Perlaky L; Harris CP; Shah S; Ladanyi M; Gorlick R; Lau CC; Rao PH
    BMC Cancer; 2004 Aug; 4():45. PubMed ID: 15298715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.